The global bioabsorbable stents market size is estimated to clock a valuation of US$ 253.9 million by 2033. Our pharmaceutical experts opine that bioabsorbable stent suppliers can expect a CAGR of 4% through 2033, with a present valuation of US$ 171.8 million in 2023.
| Attributes | Details |
|---|---|
| Bioabsorbable Stents Market Size, 2022 | US$ 167.7 million |
| Bioabsorbable Stents Market Size, 2023 | US$ 171.8 million |
| Bioabsorbable Stents Market Size, 2033 | US$ 253.9 million |
| Value CAGR (2023 to 2033) | 4% |
Trend Analysis of Bioabsorbable Stents Market
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Bioabsorbable Stents Market Size (2018) | US$ 153.40 million |
| Bioabsorbable Stents Market Size (2022) | US$ 167.7 million |
| Bioabsorbable Stents Market (CAGR 2018 to 2022) | 2.2% |
The bioabsorbable stents market accounts for a negligible share of the global stents market. However, with surging innovations and advancements in bioabsorbable stents, the market is expected to elevate at a steady pace.
As per the latest market records, the market observed a 2.2% CAGR from 2018 to 2022. The Initial generation of stents, called BMS, is composed of cobalt-chromium, tantalum, platinum-iridium alloys, nitinol, and stainless steel. However, these stents have been reworked to alleviate the number of problems or maintenance as a foreign body.
After consideration, coated stents, biodegradable stents, and drug-eluting stents came into the picture. The restenosis rate decreased as bare metal stents saw broader adoption.
Advancements in stents have led to the development of bioabsorbable stents, which can weaken and break down into natural by-products after completing their primary goal of offering judicious support for diseased lesions. Due to quick implantation, the decomposition of bioabsorbable stents is making them reachable to patients of all ages, especially children, boosting the adoption in the next decade.
Due to the widespread frequency of CVD, the demand for bioabsorbable stents is predicted to heighten owing to their efficiency and lowered adverse effects. The bioabsorbable stents market is expected to observe a CAGR of 4% through 2033.
| Country/ Region | Value Share (2022) |
|---|---|
| North America | 48.5% |
| Europe | 27.6% |
| The United States | 44.4% |
| Germany | 9.9% |
| Japan | 5.1% |
The North America market accounted for a sizeable portion of the bioabsorbable stent market in 2022, accounting for 48.5% market share. The United States captures a prominent share in the region, recording a 44.4% value share globally. The market demand for bioabsorbable stents is being influenced not only by doctors, but also by hospital administrators, regulators, and other non-clinicians. This wider circle of influencers presents distinct goals to the table, including cost-effectiveness. This shift in dynamics suggests a change in individual outcomes to an emphasis on population-level usefulness, like an overall enhancement seen in a population for a certain level of spending.
Rivalry in the medical products industry is becoming more intense. Blockbuster categories like bioabsorbable coronary stents are gaining more manufacturers as they mature. As active participants find it harder to identify a high-impact scientific innovation in the market, relatively small firms are procuring market stakes by providing innovative business models at reduced prices. Higher price transparency facilitated by the surging use of tenders in the country is giving a competitive edge to low-cost participants.
Europe is another notable market for bioabsorbable stents. As per the latest market updates, the European bioabsorbable stent market is expected to account for around 27.6% value share in 2023. Germany is predicted to register a chief position in the region. Globally, Germany’s market share is expected to clock 9.9% in 2023. The United Kingdom, which is another key player in the region, is predicted to record a CAGR of 5.7% through 2033.
The region has been an active participant in the field of bioabsorbable stents. The region kickstarted the commercial use of bioresorbable stents by giving appropriate approvals. To be precise, in January 2011, the European CE mark permitted to Absorb, Abbott drug-eluting bioresorbable coronary stent. It was the first-ever bioresorbable stent to obtain regulatory approval the world over.
Fast forward to 2023, the bioresorbable devices still embody the future of coronary stents. Key players in the region are zeroing in on long-term research on the device, with the motive of enhancing the market scope and opportunities for the respective companies. A key example of this practice is Abbott Vascular. With this in mind, companies are expected to thrive in the Europe market.
The Asia Pacific market for bioabsorbable stents paints a promising picture. Core Asian markets like China and India represent a growth of 6.6% and 4.6% CAGR. Consequently, they attract key players to build or expand their base. Surging investments in healthcare and expanding middle classes in these countries are making them a haven for premium products.
Recently, these marketplaces are showing higher growth due to innovations in pricing mechanisms and purchasing processes. Medical product manufacturers in the market have been proactive in capturing the vast opportunities available.
To gain most of the current market scene, key players need to make up their minds about their go-to-market models, tiered portfolios, business development, implications for supply chain, differentiated offerings, M&A, and cost of goods sold. With this comprehensive outlook, they would be better equipped to chart the revenue-generating opportunities in Asia Pacific.
The area of medical research is constantly evolving and currently, it also encompasses bioresorbable stents and polymer-free stents. The Japan bioabsorbable stents industry is being propelled by the increasing acceptability of stents to treat coronary artery disease (CAD). According to the latest research by FMI analysts, the bioabsorbable stents market in Japan is forecast to acquire about 5.1% in 2023.
In the past, precisely in July 2016, Japan’s Ministry of Health, Labor, and Welfare (MHLW) permitted Abbott’s Absorb bioresorbable heart stent, making this then-unique medical instrument commercially available to treat patients of coronary artery disease in Japan.
In the present competitive scene, key players are strategically advancing in the Japan market using M&A, partnerships, collaborations, and product innovation, to gain greater market share.
As per the recent analysis, the Australia market is thriving at a 6.2% CAGR through 2033. Significant untapped prospects in this landscape are fueling the market sales of bioabsorbable stents in the country. By working on improving the insufficiencies of coronary stents, key players can modify these devices to develop an optimized coronary stent. Additionally, the growing knowledge about the enhanced clinical outcomes in interventional cardiology with the use of coronary stents is expected to spur market growth.
Principal Consultant
Coronary artery stents account for a substantial share of 76.2% as of 2022. Numerous angioplasty operations drive demand for coronary stents. Angioplasty can relieve the symptoms of blocked arteries like shortness of breath and chest pains. Due to the high incidence rate of CVD, the selection of angioplasty is fueling the adoption of stent procedures. This is uplifting the demand for coronary artery stents due to their stability and efficacy in comparison to conventional stents.
As per the latest market study, polymer-made bioabsorbable stents are acquiring significant market share in the global landscape. The segment is expected to obtain about 59.3% market share in 2023. Biodegradable (BIO) polymers are capable of reducing the occurrence of subsequent complications like mal-apposition, stent strut uncovering, thrombosis, and endothelial dysfunction. Advantages of using these stents include lowered inflammatory response and entire drug elution. Therefore, polymer materials are gaining significant attention for the development of bioabsorbable stents.
Key players in the market are strategizing to enhance their product range and revise product patenting, to serve the clinical requirements of patients. Market participants release novel products and obtain regulatory approvals and licensing for distribution to improve their geographical presence.
Key Developments in the Market
Key Players in the Market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The bioabsorbable stents are worth US$ 171.8 million in 2023.
The market is expected to expand at a CAGR of 4% through 2033.
China is expected to see substantial consumption of bioabsorbable stents.
Coronary artery stents are a highly preferred product type by its end users.
Polymers are a sought-after material for bioabsorbable stents.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stents
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Stents, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Stents, 2023 to 2033
5.3.1. Coronary Artery Stents
5.3.2. Peripheral Artery Stents
5.3.3. Non-vascular Stents
5.3.3.1. Esophageal Stents
5.3.3.2. Billary Stents
5.4. Y-o-Y Growth Trend Analysis By Stents, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Stents, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2023 to 2033
6.3.1. Metallic
6.3.2. Ceramic
6.3.3. Polymers
6.3.3.1. PGA
6.3.3.2. PLA
6.3.3.3. Co-Polymer
6.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Cardiovascular
7.3.2. Orthopedics
7.3.3. Cosmetic Surgery
7.3.4. General Surgery
7.3.5. Cranial
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory surgical Centers
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Stents
10.2.3. By Material
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Stents
10.3.3. By Material
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Stents
11.2.3. By Material
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Stents
11.3.3. By Material
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Stents
12.2.3. By Material
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Stents
12.3.3. By Material
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Stents
13.2.3. By Material
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Stents
13.3.3. By Material
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Stents
14.2.3. By Material
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Stents
14.3.3. By Material
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Stents
15.2.3. By Material
15.2.4. By Application
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Stents
15.3.3. By Material
15.3.4. By Application
15.3.5. By End User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Stents
16.2.3. By Material
16.2.4. By Application
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Stents
16.3.3. By Material
16.3.4. By Application
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. U.S.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Stents
17.1.2.2. By Material
17.1.2.3. By Application
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Stents
17.2.2.2. By Material
17.2.2.3. By Application
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Stents
17.3.2.2. By Material
17.3.2.3. By Application
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Stents
17.4.2.2. By Material
17.4.2.3. By Application
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Stents
17.5.2.2. By Material
17.5.2.3. By Application
17.5.2.4. By End User
17.6. U.K.
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Stents
17.6.2.2. By Material
17.6.2.3. By Application
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Stents
17.7.2.2. By Material
17.7.2.3. By Application
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Stents
17.8.2.2. By Material
17.8.2.3. By Application
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Stents
17.9.2.2. By Material
17.9.2.3. By Application
17.9.2.4. By End User
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Stents
17.10.2.2. By Material
17.10.2.3. By Application
17.10.2.4. By End User
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Stents
17.11.2.2. By Material
17.11.2.3. By Application
17.11.2.4. By End User
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Stents
17.12.2.2. By Material
17.12.2.3. By Application
17.12.2.4. By End User
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Stents
17.13.2.2. By Material
17.13.2.3. By Application
17.13.2.4. By End User
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Stents
17.14.2.2. By Material
17.14.2.3. By Application
17.14.2.4. By End User
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Stents
17.15.2.2. By Material
17.15.2.3. By Application
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Stents
17.16.2.2. By Material
17.16.2.3. By Application
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Stents
17.17.2.2. By Material
17.17.2.3. By Application
17.17.2.4. By End User
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Stents
17.18.2.2. By Material
17.18.2.3. By Application
17.18.2.4. By End User
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Stents
17.19.2.2. By Material
17.19.2.3. By Application
17.19.2.4. By End User
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Stents
17.20.2.2. By Material
17.20.2.3. By Application
17.20.2.4. By End User
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Stents
17.21.2.2. By Material
17.21.2.3. By Application
17.21.2.4. By End User
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2022
17.22.2.1. By Stents
17.22.2.2. By Material
17.22.2.3. By Application
17.22.2.4. By End User
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2022
17.23.2.1. By Stents
17.23.2.2. By Material
17.23.2.3. By Application
17.23.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Stents
18.3.3. By Material
18.3.4. By Application
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boston Scientific Corporation
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Meril Life Sciences Pvt. Ltd.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Medtronic Plc
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. Smith & Nephew Plc
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Stryker Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Wright Medical Group
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. KLS Martin
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. BIOTRONIK Ltd
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Syntellix AG
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Q3 Medical Devices Limited.
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. JW Medical Systems LTD
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. ORBUSNEICH MEDICAL
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Abbott Vascular
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Bioabsorbable Stents Market
